Moffat G J, McLaren A W, Wolf C R
Imperial Cancer Research Fund, Molecular Pharmacology Unit, Biomedical Research Centre, Ninewells Hospital and Medical School, Dundee DD1 9SY, Scotland, U.K.
Biochem J. 1997 May 15;324 ( Pt 1)(Pt 1):91-5. doi: 10.1042/bj3240091.
Previous studies from this laboratory have identified transcriptional mechanisms that are utilized to increase expression of the human glutathione S-transferase gene GSTP1 in a multidrug-resistant derivative (VCREMS) of the human mammary carcinoma cell line MCF7 [Moffat, McLaren and Wolf (1994) J. Biol. Chem. 269, 16397-16402]. The data presented here provide strong evidence that post-transcriptional mechanisms can also play an important role in determining cell-specific expression of the GSTP1 gene. GSTP1 mRNA levels were shown to be elevated 3.1-fold in the human bladder carcinoma cell line EJ compared with VCREMS cells. Despite this observation, transient transfection assays revealed a decreased rate of GSTP1 promoter activity in EJ cells. Indeed, GSTP1 transcriptional repressor activity, mediated by a region located between nucleotides -105 and -86 (as we have previously described in MCF7 cells), was observed in EJ cells. However, in contrast with our results in MCF7 cells, the EJ repressor activity did not displace the essential nuclear complex bound to the C1 promoter element (-73 to -54) in vitro. In addition, competition experiments indicated that an AP-1-like protein is an integral component of the C1-bound complex in EJ cells. Interestingly, experiments utilizing actinomycin D to inhibit transcription demonstrated significantly greater stability of GSTP1 mRNA in EJ cells than in VCREMS cells. These findings suggest that cell-specific differences in the rates of GSTP1 mRNA decay provide the predominant mechanism responsible for elevated expression of the GSTP1 gene in EJ cells.
该实验室先前的研究已经确定了一些转录机制,这些机制被用于在人乳腺癌细胞系MCF7的多药耐药衍生物(VCREMS)中增加人谷胱甘肽S-转移酶基因GSTP1的表达[莫法特、麦克拉伦和沃尔夫(1994年)《生物化学杂志》269卷,第16397 - 16402页]。此处呈现的数据提供了有力证据,表明转录后机制在决定GSTP1基因的细胞特异性表达中也能发挥重要作用。与VCREMS细胞相比,人膀胱癌细胞系EJ中的GSTP1 mRNA水平升高了3.1倍。尽管有此观察结果,但瞬时转染试验显示EJ细胞中GSTP1启动子活性降低。实际上,在EJ细胞中观察到了由位于核苷酸-105至-86之间的区域介导的GSTP1转录抑制活性(正如我们先前在MCF7细胞中所描述的那样)。然而,与我们在MCF7细胞中的结果相反,EJ中的抑制活性在体外并未取代与C1启动子元件(-73至-54)结合的必需核复合物。此外,竞争实验表明,一种AP-1样蛋白是EJ细胞中与C1结合的复合物的一个组成部分。有趣的是,利用放线菌素D抑制转录的实验表明,EJ细胞中GSTP1 mRNA的稳定性明显高于VCREMS细胞。这些发现表明,GSTP1 mRNA衰变速率的细胞特异性差异是导致EJ细胞中GSTP1基因表达升高的主要机制。